Comparison of Quetiapine Abuse and Misuse Reports to the FDA Adverse Event Reporting System With Other Second-Generation Antipsychotics

BACKGROUND: Second-generation antipsychotics (SGAs) are assumed to have little abuse potential. However, reports of quetiapine abuse have emerged as prescribing has increased in recent years. The US Food and Drug Administration’s (FDA) Adverse Event Reporting System (FAERS) provides postmarketing in...

Descripción completa

Detalles Bibliográficos
Autores principales: Evoy, Kirk E, Teng, Chengwen, Encarnacion, Victor G, Frescas, Brian, Hakim, John, Saklad, Stephen, Frei, Christopher R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495438/
https://www.ncbi.nlm.nih.gov/pubmed/31068753
http://dx.doi.org/10.1177/1178221819844205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6495438/
https://www.ncbi.nlm.nih.gov/pubmed/31068753
http://dx.doi.org/10.1177/1178221819844205

Ejemplares similares